Publication | Open Access
Effects of angiotensin II and angiotensin-(1-7) on the release of [3H]norepinephrine from rat atria.
79
Citations
24
References
1994
Year
PharmacotherapyAng IiExperimental PharmacologyMolecular PharmacologyType 1Sodium HomeostasisVascular PharmacologyNeuropharmacologyVascular BiologyNervous SystemEndocrinologyPharmacologyRat AtriaAngiotensin IiNeurophysiologyPhysiologyNeuropeptide ReceptorAnesthesiaMedicineNeuropeptides
We examined the effects of angiotensin II (Ang II) and Ang-(1-7) on the release of [3H]norepinephrine elicited by nerve stimulation (2 Hz, 0.5 millisecond, for 2 minutes) in rat atria isolated with their cardioaccelerans nerves. The stimulation-induced release of [3H]norepinephrine was increased 50% by 3 x 10(-8) mol/L of either peptide. No further increase in [3H]norepinephrine release was observed with peptide concentrations up to 3 x 10(-7) mol/L. This effect was completely blocked by the nonselective angiotensin receptor antagonist saralasin (1 x 10(-7) mol/L). The type 1 angiotensin receptor antagonist DuP 753 (1 x 10(-6) mol/L) entirely prevented the increases in [3H]norepinephrine caused by Ang II and Ang-(1-7). On the other hand, the type 2 angiotensin receptor antagonist PD 123319 (1 x 10(-6) mol/L) prevented the increase in [3H]norepinephrine release elicited by Ang-(1-7) but not by Ang II. These results suggest that Ang-(1-7), like Ang II, could have a neuromodulatory function in rat atria via activation of specific angiotensin receptor subtypes, which could be the subtype 1 angiotensin receptor for Ang II and subtypes 1 and 2 for Ang-(1-7).
| Year | Citations | |
|---|---|---|
Page 1
Page 1